Enhanced intracellular survival and epithelial cell adherence abilities of Burkholderia pseudomallei morphotypes are dependent on differential expression of virulence-associated proteins during mid-logarithmic growth phase

Journal of Proteomics

Volumn 106, Issue , 2014, Pages 205-220

  Al Maleki, Anis Rageh ^a   Mariappan, Vanitha ^a   Vellasamy, Kumutha Malar ^a   Shankar, Esaki Muthu ^a   Tay, Sun Tee ^a   Vadivelu, Jamuna ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Burkholderia pseudomallei; Colony variants; Pathogenesis; Proteomics

Indexed keywords

DNA BINDING PROTEIN; ELONGATION FACTOR; ENOLASE; FERRITIN; NUCLEOSIDE DIPHOSPHATE KINASE; OXIDOREDUCTASE; PHOSPHOGLYCERATE KINASE; THIOREDOXIN; VIRULENCE FACTOR; BACTERIAL PROTEIN; BIOLOGICAL MARKER; PROTEOME;

ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM COLONY; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MORPHOTYPE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WILD TYPE; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MASS SPECTROMETRY; MELIOIDOSIS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PROTEIN DATABASE; PROTEOMICS; TUMOR CELL LINE; VIRULENCE;

BACTERIAL ADHESION; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; BURKHOLDERIA PSEUDOMALLEI; CELL LINE, TUMOR; DATABASES, PROTEIN; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MASS SPECTROMETRY; MELIOIDOSIS; PROTEOME; PROTEOMICS; VIRULENCE; VIRULENCE FACTORS;

EID: 84900811195     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.04.005     Document Type: Article

References (110)

1. White N.J. Melioidosis. Lancet 2003, 361:1715-1722.
2. Currie B.J., Jacups S.P. Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis 2003, 9:1538-1542.
3. Currie B.J., Jacups S.P., Cheng A.C., Fisher D.A., Anstey N.M., Huffam S.E., et al. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop Med Int Health 2004, 9:1167-1174.
4. Leelarasamee A. Recent development in melioidosis. Curr Opin Infect Dis 2004, 17:131-136.
5. Ngauy V., Lemeshev Y., Sadkowski L., Crawford G. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol 2005, 43:970-972.
6. Chaowagul W., Suputtamongkol Y., Dance D.A., Rajchanuvong A., Pattara-arechachai J., White N.J. Relapse in melioidosis: incidence and risk factors. J Infect Dis 1993, 168:1181-1185.
7. Wiersinga W.J., van der Poll T., White N.J., Day N.P., Peacock S.J. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 2006, 4:272-282.
8. Lazar Adler N.R., Govan B., Cullinane M., Harper M., Adler B., Boyce J.D. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?. FEMS Microbiol Rev 2009, 33:1079-1099.
9. Chantratita N., Wuthiekanun V., Boonbumrung K., Tiyawisutsri R., Vesaratchavest M., Limmathurotsakul D., et al. Biological relevance of colony morphology and phenotypic switching by Burkholderia pseudomallei. J Bacteriol 2007, 189:807-817.
10. Bryan L.E., Kwan S. Aminoglycoside-resistant mutants of Pseudomonas aeruginosa deficient in cytochrome d, nitrite reductase, and aerobic transport. Antimicrob Agents Chemother 1981, 19:958-964.
11. Haussler S., Lehmann C., Breselge C., Rohde M., Classen M., Tummler B., et al. Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex. Eur J Clin Microbiol Infect Dis 2003, 22:249-253.
12. Pranting M., Andersson D.I. Escape from growth restriction in small colony variants of Salmonella typhimurium by gene amplification and mutation. Mol Microbiol 2011, 79:305-315.
13. Swingle E.L. Studies on small colony variants of Staphylococcus aureus. J Bacteriol 1935, 29:467-489.
14. Duff D.C. Dissociation in Bacillus salmonicida, with special reference to the appearance of a G form of culture. J Bacteriol 1937, 34:49-67.
15. Colwell C.A. Small colony variants of Escherichia coli. J Bacteriol 1946, 52:417-422.
16. Mowjood M., Miller F.E., Schor J., Kocka F.E. Small-colony forms of enteric bacteria after exposure to aminoglycosides. Am J Clin Pathol 1979, 72:79-81.
17. Proctor R.A., von Eiff C., Kahl B.C., Becker K., McNamara P., Herrmann M., et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006, 4:295-305.
18. Tandhavanant S., Thanwisai A., Limmathurotsakul D., Korbsrisate S., Day N.P., Peacock S.J., et al. Effect of colony morphology variation of Burkholderia pseudomallei on intracellular survival and resistance to antimicrobial environments in human macrophages in vitro. BMC Microbiol 2010, 10:303.
19. Ramli N.S., Eng Guan C., Nathan S., Vadivelu J. The effect of environmental conditions on biofilm formation of Burkholderia pseudomallei clinical isolates. PLoS ONE 2012, 7:e44104.
20. Haussler S., Rohde M., Steinmetz I. Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis. Med Microbiol Immunol 1999, 188:91-97.
21. Suputtamongkol Y., Rajchanuwong A., Chaowagul W., Dance D.A., Smith M.D., Wuthiekanun V., et al. Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis. Clin. Infect. Dis. 1994, 19:846-853.
22. Vorachit M., Lam K., Jayanetra P., Costerton J.W. Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic discs to ceftazidime and co-trimoxazole. Antimicrob Agents Chemother 1993, 37:2000-2002.
23. Suppiah J., Thimma J.S., Cheah S.H., Vadivelu J. Development and evaluation of polymerase chain reaction assay to detect Burkholderia genus and to differentiate the species in clinical specimens. FEMS Microbiol Lett 2010, 306:9-14.
24. Vellasamy K.M., Mariappan V., Hashim O.H., Vadivelu J. Identification of immunoreactive secretory proteins from the stationary phase culture of Burkholderia pseudomallei. Electrophoresis 2011, 32:310-320.
25. Miles A.A., Misra S.S., Irwin J.O. The estimation of the bactericidal power of the blood. J Hyg 1938, 38:732-749.
26. Kespichayawattana W., Intachote P., Utaisincharoen P., Sirisinha S. Virulent Burkholderia pseudomallei is more efficient than avirulent Burkholderia thailandensis in invasion of and adherence to cultured human epithelial cells. Microb Pathog 2004, 36:287-292.
27. Oaks E.V., Wingfield M.E., Formal S.B. Plaque formation by virulent Shigella flexneri. Infect Immun 1985, 48:124-129.
28. Mariappan V., Vellasamy K.M., Thimma J.S., Hashim O.H., Vadivelu J. Identification of immunogenic proteins from Burkholderia cepacia secretome using proteomic analysis. Vaccine 2010, 28:1318-1324.
29. Lee S.H., Chong C.E., Lim B.S., Chai S.J., Sam K.K., Mohamed R., et al. Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics. Diagn Microbiol Infect Dis 2007, 58:263-270.
30. Savoia D., Zucca M. Clinical and environmental Burkholderia strains: biofilm production and intracellular survival. Curr Microbiol 2007, 54:440-444.
31. Proctor R.A., van Langevelde P., Kristjansson M., Maslow J.N., Arbeit R.D. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin. Infect. Dis. 1995, 20:95-102.
32. Tuchscherr L., Heitmann V., Hussain M., Viemann D., Roth J., von Eiff C., et al. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis 2010, 202:1031-1040.
33. von Eiff C., Becker K., Metze D., Lubritz G., Hockmann J., Schwarz T., et al. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clin Infect Dis 2001, 32:1643-1647.
34. Ahmed K., Enciso H.D., Masaki H., Tao M., Omori A., Tharavichikul P., et al. Attachment of Burkholderia pseudomallei to pharyngeal epithelial cells: a highly pathogenic bacteria with low attachment ability. AmJTrop Med Hyg 1999, 60:90-93.
35. Brown N.F., Boddey J.A., Flegg C.P., Beacham I.R. Adherence of Burkholderia pseudomallei cells to cultured human epithelial cell lines is regulated by growth temperature. Infect Immun 2002, 70:974-980.
36. Utaisincharoen P., Arjcharoen S., Lengwehasatit I., Limposuwan K., Sirisinha S. Burkholderia pseudomallei invasion and activation of epithelial cells requires activation of p38 mitogen-activated protein kinase. Microb Pathog 2005, 38:107-112.
37. Padilla D., Acosta F., Bravo J., Grasso V., Real F., Vivas J. Invasion and intracellular survival of Hafnia alvei strains in human epithelial cells. J Appl Microbiol 2008, 105:1614-1622.
38. Guzman C.A., Rohde M., Bock M., Timmis K.N. Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells. Infect Immun 1994, 62:5528-5537.
39. Deziel E., Comeau Y., Villemur R. Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities. J Bacteriol 2001, 183:1195-1204.
40. Taweechaisupapong S., Kaewpa C., Arunyanart C., Kanla P., Homchampa P., Sirisinha S., et al. Virulence of Burkholderia pseudomallei does not correlate with biofilm formation. Microb Pathog 2005, 39:77-85.
41. Boddey J.A., Flegg C.P., Day C.J., Beacham I.R., Peak I.R. Temperature-regulated microcolony formation by Burkholderia pseudomallei requires pilA and enhances association with cultured human cells. Infect Immun 2006, 74:5374-5381.
42. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
43. Vestby L.K., Moretro T., Langsrud S., Heir E., Nesse L.L. Biofilm forming abilities of Salmonella are correlated with persistence in fish meal- and feed factories. BMC Vet Res 2009, 5:20.
44. Suparak S., Kespichayawattana W., Haque A., Easton A., Damnin S., Lertmemongkolchai G., et al. Multinucleated giant cell formation and apoptosis in infected host cells is mediated by Burkholderia pseudomallei type III secretion protein BipB. J Bacteriol 2005, 187:6556-6560.
45. Chantratita N., Tandhavanant S., Wikraiphat C., Trunck L.A., Rholl D.A., Thanwisai A., et al. Proteomic analysis of colony morphology variants of Burkholderia pseudomallei defines a role for the arginine deiminase system in bacterial survival. J Proteome 2012, 75:1031-1042.
46. Kirisits M.J., Prost L., Starkey M., Parsek M.R. Characterization of colony morphology variants isolated from Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2005, 71:4809-4821.
47. Vipond J., Kane J., Hatch G., McCorrison J., Nierman W.C., Losada L. Sequence determination of Burkholderia pseudomallei strain NCTC 13392 colony morphology variants. Genome Announcements 2013, 1.
48. Wongtrakoongate P., Roytrakul S., Yasothornsrikul S., Tungpradabkul S. A proteome reference map of the causative agent of melioidosis Burkholderia pseudomallei. J Biomed Biotechnol 2011, 2011:530926.
49. Cohen D.P., Renes J., Bouwman F.G., Zoetendal E.G., Mariman E., de Vos W.M., et al. Proteomic analysis of log to stationary growth phase Lactobacillus plantarum cells and a 2-DE database. Proteomics 2006, 6:6485-6493.
50. Chodavarapu S., Gomez R., Vicente M., Kaguni J.M. Escherichia coli Dps interacts with DnaA protein to impede initiation: a model of adaptive mutation. Mol Microbiol 2008, 67:1331-1346.
51. Haikarainen T., Papageorgiou A.C. Dps-like proteins: structural and functional insights into a versatile protein family. Cell Mol Life Sci 2010, 67:341-351.
52. Chutoam P., Charoensawan V., Wongtrakoongate P., Kum-Arth A., Buphamalai P., Tungpradabkul S. RpoS and oxidative stress conditions regulate succinyl-CoA: 3-ketoacid-coenzyme A transferase (SCOT) expression in Burkholderia pseudomallei. Microbiol Immunol 2013, 57:605-615.
53. Wongtrakoongate P., Tumapa S., Tungpradabkul S. Regulation of a quorum sensing system by stationary phase sigma factor RpoS and their co-regulation of target genes in Burkholderia pseudomallei. Microbiol Immunol 2012, 56:281-294.
54. Lumjiaktase P., Diggle S.P., Loprasert S., Tungpradabkul S., Daykin M., Camara M., et al. Quorum sensing regulates dpsA and the oxidative stress response in Burkholderia pseudomallei. Microbiology 2006, 152:3651-3659.
55. Dunny G.M., Leonard B.A. Cell-cell communication in gram-positive bacteria. Annu Rev Microbiol 1997, 51:527-564.
56. Williams P., Camara M., Hardman A., Swift S., Milton D., Hope V.J., et al. Quorum sensing and the population-dependent control of virulence. Philos Trans R Soc Lond B Biol Sci 2000, 355:667-680.
57. Jayaraman A., Wood T.K. Bacterial quorum sensing: signals, circuits, and implications for biofilms and disease. Annu Rev Biomed Eng 2008, 10:145-167.
58. Rosen R., Sacher A., Shechter N., Becher D., Buttner K., Biran D., et al. Two-dimensional reference map of Agrobacterium tumefaciens proteins. Proteomics 2004, 4:1061-1073.
59. Park M.R., Lee E.G., Kim Y.H., Jung T.S., Shin Y.S., Shin G.W., et al. Reference map of soluble proteins from Salmonella enterica serovar Enteritidis by two-dimensional electrophoresis. J Vet Sci 2003, 4:143-149.
60. Wongtrakoongate P., Mongkoldhumrongkul N., Chaijan S., Kamchonwongpaisan S., Tungpradabkul S. Comparative proteomic profiles and the potential markers between Burkholderia pseudomallei and Burkholderia thailandensis. Mol Cell Probes 2007, 21:81-91.
61. Holden M.T., Titball R.W., Peacock S.J., Cerdeno-Tarraga A.M., Atkins T., Crossman L.C., et al. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci U S A 2004, 101:14240-14245.
62. Galyov E.E., Brett P.J., DeShazer D. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annu Rev Microbiol 2010, 64:495-517.
63. Ulrich R.L., DeShazer D. Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei. Infect Immun 2004, 72:1150-1154.
64. Chuaygud T., Tungpradabkul S., Sirisinha S., Chua K.L., Utaisincharoen P. A role of Burkholderia pseudomallei flagella as a virulent factor. Trans R Soc Trop Med Hyg 2008, 102(Suppl. 1):S140-S144.
65. Stevens M.P., Haque A., Atkins T., Hill J., Wood M.W., Easton A., et al. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology 2004, 150:2669-2676.
66. Wolf S.G., Frenkiel D., Arad T., Finkel S.E., Kolter R., Minsky A. DNA protection by stress-induced biocrystallization. Nature 1999, 400:83-85.
67. Choi S.H., Baumler D.J., Kaspar C.W. Contribution of dps to acid stress tolerance and oxidative stress tolerance in Escherichia coli O157:H7. Appl Environ Microbiol 2000, 66:3911-3916.
68. Halsey T.A., Vazquez-Torres A., Gravdahl D.J., Fang F.C., Libby S.J. The ferritin-like Dps protein is required for Salmonella enterica serovar Typhimurium oxidative stress resistance and virulence. Infect Immun 2004, 72:1155-1158.
69. Jung I.L.K.I. Transcriptional of alpC, katG, and katE genes in Escherichia coli is regulated by polyamines: polyamine deficient mutant sensitive to H2O2-induced oxidative damage. Biochem Biophys Res Commun 2003, 301:915-922.
70. Hassett D.J., Ma J.F., Elkins J.G., McDermott T.R., Ochsner U.A., West S.E., et al. Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol Microbiol 1999, 34:1082-1093.
71. Sherman D.R., Mdluli K., Hickey M.J., Barry C.E., Stover C.K. AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis. Biofactors 1999, 10:211-217.
72. Master S.S., Springer B., Sander P., Boettger E.C., Deretic V., Timmins G.S. Oxidative stress response genes in Mycobacterium tuberculosis: role of ahpC in resistance to peroxynitrite and stage-specific survival in macrophages. Microbiology 2002, 148:3139-3144.
73. Trant C.G., Lacerda T.L., Carvalho N.B., Azevedo V., Rosinha G.M., Salcedo S.P., et al. The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice. Infect Immun 2010, 78:2283-2291.
74. Sun J., Wang X., Lau A., Liao T.Y., Bucci C., Hmama Z. Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages. PLoS ONE 2010, 5:e8769.
75. Arai R.J., Ogata F.T., Batista W.L., Masutani H., Yodoi J., Debbas V., et al. Thioredoxin-1 promotes survival in cells exposed to S-nitrosoglutathione: correlation with reduction of intracellular levels of nitrosothiols and up-regulation of the ERK1/2 MAP Kinases. Toxicol Appl Pharmacol 2008, 233:227-237.
76. Uziel O., Borovok I., Schreiber R., Cohen G., Aharonowitz Y. Transcriptional regulation of the Staphylococcus aureus thioredoxin and thioredoxin reductase genes in response to oxygen and disulfide stress. J Bacteriol 2004, 186:326-334.
77. Leichert L.I., Scharf C., Hecker M. Global characterization of disulfide stress in Bacillus subtilis. J Bacteriol 2003, 185:1967-1975.
78. Mostertz J., Hochgrafe F., Jurgen B., Schweder T., Hecker M. The role of thioredoxin TrxA in Bacillus subtilis: a proteomics and transcriptomics approach. Proteomics 2008, 8:2676-2690.
79. Imlay J.A. Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem 2008, 77:755-776.
80. Subsin B., Thomas M.S., Katzenmeier G., Shaw J.G., Tungpradabkul S., Kunakorn M. Role of the stationary growth phase sigma factor RpoS of Burkholderia pseudomallei in response to physiological stress conditions. J Bacteriol 2003, 185:7008-7014.
81. Zhang A., Chen B., Mu X., Li R., Zheng P., Zhao Y., et al. Identification and characterization of a novel protective antigen, Enolase of Streptococcus suis serotype 2. Vaccine 2009, 27:1348-1353.
82. Shih K-JLaN-Y. The role of enolase in tissue invasion and metastasis of pathogens and tumor cells. J Cancer Mol 2007, 3(2):4.
83. Sha J., Erova T.E., Alyea R.A., Wang S., Olano J.P., Pancholi V., et al. Surface-expressed enolase contributes to the pathogenesis of clinical isolate SSU of Aeromonas hydrophila. J Bacteriol 2009, 191:3095-3107.
84. Liu W.T., Karavolos M.H., Bulmer D.M., Allaoui A., Hormaeche R.D., Lee J.J., et al. Role of the universal stress protein UspA of Salmonella in growth arrest, stress and virulence. Microb Pathog 2007, 42:2-10.
85. Harding S.V., Sarkar-Tyson M., Smither S.J., Atkins T.P., Oyston P.C., Brown K.A., et al. The identification of surface proteins of Burkholderia pseudomallei. Vaccine 2007, 25:2664-2672.
86. Kunert A., Losse J., Gruszin C., Huhn M., Kaendler K., Mikkat S., et al. Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J Immunol 2007, 179:2979-2988.
87. Hamad M.A., Austin C.R., Stewart A.L., Higgins M., Vazquez-Torres A., Voskuil M.I. Adaptation and antibiotic tolerance of anaerobic Burkholderia pseudomallei. Antimicrob Agents Chemother 2011, 55:3313-3323.
88. Seifart Gomes C., Izar B., Pazan F., Mohamed W., Mraheil M.A., Mukherjee K., et al. Universal stress proteins are important for oxidative and acid stress resistance and growth of Listeria monocytogenes EGD-e in vitro and in vivo. PLoS ONE 2011, 6:e24965.
89. Barel M., Hovanessian A.G., Meibom K., Briand J.P., Dupuis M., Charbit A. A novel receptor-ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu. BMC Microbiol 2008, 8:145.
90. Balasubramanian S., Kannan T.R., Baseman J.B. The surface-exposed carboxyl region of Mycoplasma pneumoniae elongation factor Tu interacts with fibronectin. Infect Immun 2008, 76:3116-3123.
91. Nachin L., Nannmark U., Nystrom T. Differential roles of the universal stress proteins of Escherichia coli in oxidative stress resistance, adhesion, and motility. J Bacteriol 2005, 187:6265-6272.
92. Peters S.E., Paterson G.K., Bandularatne E.S., Northen H.C., Pleasance S., Willers C., et al. Salmonella enterica serovar Typhimurium trxA mutants are protective against virulent challenge and induce less inflammation than the live-attenuated vaccine strain SL3261. Infect Immun 2010, 78:326-336.
93. Walzl G., Ronacher K., Hanekom W., Scriba T.J., Zumla A. Immunological biomarkers of tuberculosis. Nat Rev Immunol 2011, 11:343-354.
94. Sartain M.J., Slayden R.A., Singh K.K., Laal S., Belisle J.T. Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling. Mol Cell Proteomics 2006, 5:2102-2113.
95. Theoret J.R., Cooper K.K., Zekarias B., Roland K.L., Law B.F., Curtiss R., et al. The Campylobacter jejuni Dps homologue is important for in vitro biofilm formation and cecal colonization of poultry and may serve as a protective antigen for vaccination. Clin Vaccine Immunol 2012, 19:1426-1431.
96. O'Riordan A.A., Morales V.A., Mulligan L., Faheem N., Windle H.J., Kelleher D.P. Alkyl hydroperoxide reductase: a candidate Helicobacter pylori vaccine. Vaccine 2012, 30:3876-3884.
97. Mehmood K., Hasan F. Construction and use of a prokaryotic expression system for Helicobacter pylori AhpC. BMC Res Notes 2012, 5:328.
98. Wu M.S., Chow L.P., Lin J.T., Chiou S.H. Proteomic identification of biomarkers related to Helicobacter pylori-associated gastroduodenal disease: challenges and opportunities. J Gastroenterol Hepatol 2008, 23:1657-1661.
99. Nieves W., Heang J., Asakrah S., Honer Zu Bentrup K., Roy C.J., Morici L.A. Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization. PLoS ONE 2010, 5:e14361.
100. Hennequin C., Porcheray F., Waligora-Dupriet A., Collignon A., Barc M., Bourlioux P., et al. GroEL (Hsp60) of Clostridium difficile is involved in cell adherence. Microbiology 2001, 147:87-96.
101. Thongboonkerd V., Luengpailin J., Cao J., Pierce W.M., Cai J., Klein J.B., et al. Fluoride exposure attenuates expression of Streptococcus pyogenes virulence factors. J Biol Chem 2002, 277:16599-16605.
102. Ramnath M., Rechinger K.B., Jansch L., Hastings J.W., Knochel S., Gravesen A. Development of a Listeria monocytogenes EGDe partial proteome reference map and comparison with the protein profiles of food isolates. Appl Environ Microbiol 2003, 69:3368-3376.
103. Heim S., Ferrer M., Heuer H., Regenhardt D., Nimtz M., Timmis K.N. Proteome reference map of Pseudomonas putida strain KT2440 for genome expression profiling: distinct responses of KT2440 and Pseudomonas aeruginosa strain PAO1 to iron deprivation and a new form of superoxide dismutase. Environ Microbiol 2003, 5:1257-1269.
104. Wang Y., Sorensen M.G., Zheng Q., Zhang C., Karsdal M.A., Henriksen K. Will posttranslational modifications of brain proteins provide novel serological markers for dementias?. Int J Alzheimers Dis 2012, 2012:209409.
105. Leach M.D., Brown A.J. Posttranslational modifications of proteins in the pathobiology of medically relevant fungi. Eukaryot Cell 2012, 11:98-108.
106. Dunne J.L., Overbergh L., Purcell A.W., Mathieu C. Posttranslational modifications of proteins in type 1 diabetes: the next step in finding the cure?. Diabetes 2012, 61:1907-1914.
107. Winter D.L., Paulin D., Mericskay M., Li Z. Posttranslational modifications of desmin and their implication in biological processes and pathologies. Histochem Cell Biol 2014, 141:1-16.
108. Mariappan V., Vellasamy K.M., Hashim O.H., Vadivelu J. Profiling of Burkholderia cepacia secretome at mid-logarithmic and early-stationary phases of growth. PLoS ONE 2011, 6:e26518.
109. Ovchinnikov Y.A., Lipkin V.M., Modyanov N.N., Chertov O.Y., Smirnov Y.V. Primary structure of alpha-subunit of DNA-dependent RNA polymerase from Escherichia coli. FEBS Lett 1977, 76:108-111.
110. Meek D.W., Hayward R.S. Nucleotide sequence of the rpoA-rplQ DNA of Escherichia coli: a second regulatory binding site for protein S4?. Nucleic Acids Res 1984, 12:5813-5821.